Keel Point’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.2M Sell
25,357
-7,019
-22% -$1.63M 0.41% 39
2025
Q4
$6.7M Sell
32,376
-2,467
-7% -$488K 0.4% 41
2025
Q3
$6.46M Sell
34,843
-176
-0.5% -$30.2K 0.4% 41
2025
Q2
$5.35M Buy
35,019
+385
+1% +$59.2K 0.35% 45
2025
Q1
$5.74M Buy
34,634
+3,478
+11% +$544K 0.45% 37
2024
Q4
$4.51M Sell
31,156
-2,247
-7% -$348K 0.36% 48
2024
Q3
$5.41M Buy
33,403
+259
+0.8% +$41.3K 0.45% 34
2024
Q2
$5.25M Buy
33,144
+1,794
+6% +$267K 0.47% 35
2024
Q1
$4.96M Buy
31,350
+3,582
+13% +$570K 0.51% 36
2023
Q4
$4.35M Sell
27,768
-437
-2% -$67K 0.52% 34
2023
Q3
$4.39M Sell
28,205
-898
-3% -$148K 0.6% 28
2023
Q2
$4.82M Buy
29,103
+1,613
+6% +$260K 0.64% 27
2023
Q1
$4.26M Sell
27,490
-1,103
-4% -$178K 0.62% 29
2022
Q4
$5.05M Buy
28,593
+930
+3% +$161K 0.79% 24
2022
Q3
$4.52M Buy
27,663
+120
+0.4% +$20.3K 0.78% 24
2022
Q2
$4.7M Sell
27,543
-1,104
-4% -$197K 0.73% 26
2022
Q1
$5.08M Sell
28,647
-16,266
-36% -$2.77M 0.76% 29
2021
Q4
$7.68M Buy
44,913
+1,157
+3% +$189K 0.86% 20
2021
Q3
$7.07M Buy
43,756
+1,635
+4% +$279K 0.91% 24
2021
Q2
$6.94M Buy
42,121
+2,008
+5% +$332K 0.77% 25
2021
Q1
$6.59M Buy
40,113
+479
+1% +$77.5K 0.64% 28
2020
Q4
$6.24M Buy
39,634
+3,984
+11% +$588K 0.56% 31
2020
Q3
$5.31M Buy
35,650
+22,090
+163% +$3.27M 0.48% 30
2020
Q2
$1.91M Sell
13,560
-389
-3% -$56.7K 0.2% 54
2020
Q1
$1.83M Buy
13,949
+1,256
+10% +$178K 0.24% 46
2019
Q4
$1.85M Buy
12,693
+2,024
+19% +$275K 0.2% 52
2019
Q3
$1.38M Buy
10,669
+434
+4% +$57.2K 0.17% 56
2019
Q2
$1.43M Buy
10,235
+1,231
+14% +$170K 0.16% 58
2019
Q1
$1.26M Buy
9,004
+1,198
+15% +$160K 0.15% 61
2018
Q4
$1.01M Buy
7,806
+2,251
+41% +$314K 0.14% 61
2018
Q3
$768K Buy
5,555
+714
+15% +$94.9K 0.1% 71
2018
Q2
$587K Sell
4,841
-1,033
-18% -$129K 0.08% 82
2018
Q1
$753K Sell
5,874
-179
-3% -$24.2K 0.1% 62
2017
Q4
$846K Sell
6,053
-472
-7% -$65.7K 0.12% 64
2017
Q3
$848K Sell
6,525
-215
-3% -$28.5K 0.13% 64
2017
Q2
$892K Buy
6,740
+338
+5% +$43.1K 0.18% 57
2017
Q1
$797K Buy
6,402
+24
+0.4% +$2.87K 0.16% 63
2016
Q4
$735K Sell
6,378
-430
-6% -$49.7K 0.17% 63
2016
Q3
$804K Buy
6,808
+2,623
+63% +$318K 0.31% 51
2016
Q2
$508K Buy
4,185
+167
+4% +$19K 0.22% 76
2016
Q1
$435K Sell
4,018
-210
-5% -$21.7K 0.22% 81
2015
Q4
$434K Sell
4,228
-602
-12% -$60.5K 0.23% 82
2015
Q3
$451K Buy
4,830
+150
+3% +$14.5K 0.25% 65
2015
Q2
$467K Sell
4,680
-437
-9% -$43.8K 0.22% 63
2015
Q1
$515K Buy
+5,117
New +$520K 0.26% 59

Other funds holding JNJ

Keel Point's JNJ Position: Q1 2026 in Review

Keel Point reduced its Johnson & Johnson (JNJ) stake by 22% in Q1 2026, selling an estimated $1.63M and leaving 25,357 shares worth $6.2M. The position accounts for 0.41% of the portfolio, ranked #39.

Keel Point first reported a position in JNJ in Q1 2015 and has held it in 45 quarters since. The position peaked at $7.68M in Q4 2021. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Keel Point held 25,357 shares of Johnson & Johnson worth $6.2M as of Q1 2026.
  • Keel Point sold 7,019 Johnson & Johnson shares in Q1 2026, an estimated $1.63M.
  • Johnson & Johnson made up 0.41% of Keel Point's portfolio in Q1 2026, its #39 holding.
  • Keel Point first reported a position in Johnson & Johnson in Q1 2015 and has held it in 45 quarters since.
  • Keel Point's Johnson & Johnson position peaked at $7.68M in Q4 2021.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Keel Point's 13F filing for Q1 2026, filed 1 Jun 2026.